Euroimmun is modernizing its brand appearance Our company has undergone significant developments in recent years. This will now also be reflected in our visual appearance. At the ADLM in Chicago (July 27–31, 2025), we will show you our new, modernized look for the first time, underlining our innovative power and our international orientation. But, of […]
On 15th April 2025, the European Commission authorised lecanemab (monoclonal anti-amyloid (beta) antibody; trade name: Leqembi from Eisai and Biogen) in the European Union to treat early Alzheimer’s disease. A decision was long awaited after the positive opinion on the marketing authorisation of the medicine by the European Medicines Agency (EMA) in November 2024. The
If a child grows significantly slower or is much smaller than their peers, parents generally get worried. While this may just be a temporary delay that balances out in later growth phases, a lack of growth can also have endocrine causes and may persist: Such growth disorders require treatment and stem from a lack of
Reliability, versatility and usability of automation solutions are crucial in diagnostic laboratories. The random access device IDS i20 joins the IDS-i10 and IDS-iSYS in the i-series and was developed to fulfil precisely these requirements for the processing of chemiluminescence immunoassays (ChLIA). This makes it possible to maximise standards even with high sample numbers, to minimise
As Mary S. (71) puts down her heavy shopping bag, she suddenly feels a sharp pain in her forearm. Her general practitioner, whom she visits the next day, immediately refers her to radiology. The x-ray confirms the suspected diagnosis of a fractured radius. But that is not all. Mary also appears to suffer from osteoporosis,
